Raffles Medical Group Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Raffles Medical Group ha aumentado sus beneficios a una tasa media anual de 17.7%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 15.1% anual. Los ingresos han ido creciendo a una tasa media de 10.8% al año. La rentabilidad financiera de Raffles Medical Group es de 8.7%, y sus márgenes netos son de 12.7%.

Información clave

17.7%

Tasa de crecimiento de los beneficios

16.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	9.7%
Tasa de crecimiento de los ingresos	10.8%
Rentabilidad financiera	8.7%
Margen neto	12.7%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

May 09

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25

Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?

Apr 05

Returns On Capital At Raffles Medical Group (SGX:BSL) Paint A Concerning Picture

Mar 24

Is Raffles Medical Group (SGX:BSL) Using Too Much Debt?

Mar 12

Robust Earnings May Not Tell The Whole Story For Raffles Medical Group (SGX:BSL)

Feb 28

Insider Buying: The Raffles Medical Group Ltd (SGX:BSL) Executive Chairman & CEO Just Bought S$1.5m Worth Of Shares

Feb 24

What Is Raffles Medical Group Ltd's (SGX:BSL) Share Price Doing?

Feb 22

Desglose de ingresos y gastos

Cómo gana y gasta dinero Raffles Medical Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

SGX:BSL Ingresos, gastos y beneficios (SGD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	708	90	142
30 Sep 23	747	117	123
30 Jun 23	730	144	0
31 Mar 23	749	144	3
31 Dec 22	825	143	110
30 Sep 22	808	124	62
30 Jun 22	791	104	13
31 Mar 22	758	94	10
31 Dec 21	725	84	7
30 Sep 21	698	86	7
30 Jun 21	671	88	7
31 Mar 21	619	77	7
31 Dec 20	568	66	7
30 Sep 20	541	60	9
30 Jun 20	508	50	8
31 Mar 20	514	55	9
31 Dec 19	522	60	10
30 Sep 19	514	63	14
30 Jun 19	504	66	16
31 Mar 19	497	69	15
31 Dec 18	489	71	20
30 Sep 18	484	71	18
30 Jun 18	483	71	17
31 Mar 18	483	71	16
31 Dec 17	478	71	15
30 Sep 17	473	70	16
30 Jun 17	473	70	16
31 Mar 17	472	70	16
31 Dec 16	474	70	16
30 Sep 16	470	71	16
30 Jun 16	452	71	15
31 Mar 16	432	70	14
31 Dec 15	411	69	13
30 Sep 15	396	69	11
30 Jun 15	389	68	11
31 Mar 15	382	68	10
31 Dec 14	375	68	10
30 Sep 14	363	89	9
30 Jun 14	353	87	9
31 Mar 14	347	86	9
31 Dec 13	341	85	9
30 Sep 13	336	62	8
30 Jun 13	330	61	8

Ingresos de calidad: BSL tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(12.7%) de BSL son inferiores a los del año pasado (17.4%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de BSL han crecido un 17.7% al año en los últimos 5 años.

Acelerando crecimiento: BSL ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: BSL tuvo un crecimiento negativo de los beneficios (-37.1%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (-2%).

Raffles Medical Group Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS misses analyst expectations

First half 2023 earnings released: EPS: S$0.032 (vs S$0.032 in 1H 2022)

Raffles Medical Group Ltd to Report First Half, 2023 Results on Jul 31, 2023

Full year 2022 earnings: Revenues in line with analyst expectations

Full year 2022 earnings: EPS exceeds analyst expectations

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

Executive Chairman & CEO recently bought S$500k worth of stock

Upcoming dividend of S$0.024 per share

Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS misses analyst expectations

Now 20% undervalued

Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Price target decreased by 12% to S$1.14

Consensus EPS estimates fall by 21%

Executive Chairman & CEO recently bought S$3.6m worth of stock

Dividend of S$0.024 announced

Raffles Medical Group Ltd, Annual General Meeting, Apr 26, 2024

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Investor sentiment deteriorates as stock falls 15%

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Raffles Medical Group Ltd Announces Resignation of Soo Yu-Han Jessica as Joint Company Secretary, Effective 8 August 2023

High number of new directors

First half 2023 earnings released: EPS: S$0.032 (vs S$0.032 in 1H 2022)

Raffles Medical Group Ltd Announces Appointment of Lu Liangjian as Non-Executive and Non-Independent Director

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group Ltd to Report First Half, 2023 Results on Jul 31, 2023

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Upcoming dividend of S$0.038 per share at 2.6% yield

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Full year 2022 earnings: Revenues in line with analyst expectations

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Price target increased by 8.1% to S$1.72

Full year 2022 earnings: EPS exceeds analyst expectations

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group Ltd to Report Fiscal Year 2022 Results on Feb 27, 2023

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Now 21% undervalued

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Now 21% undervalued

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Now 20% undervalued

Investor sentiment improved over the past week

Price target increased to S$1.52

Executive Chairman & CEO recently bought S$63k worth of stock

First half 2022 earnings released

Raffles Medical Group Ltd to Report First Half, 2022 Results on Aug 01, 2022

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Raffles Medical Group Ltd Approves Final Dividend for the Year Ended 31 December 2021

Raffles Medical Group Ltd Approves Final Dividend for the Year Ended 31 December 2021

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Upcoming dividend of S$0.028 per share

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

Price target decreased to S$1.39

Raffles Medical Group Ltd Approves the Ordinary (One-Tier Tax Exempt) Core Dividend for the Financial Year Ended December 31, 2021, Payable on May 19, 2022

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Raffles Medical Group Ltd Proposes One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2021

Raffles Medical Group Ltd, Annual General Meeting, Apr 25, 2022

Executive Chairman & CEO recently bought S$595k worth of stock

Price target decreased to S$1.39

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Raffles Medical Group Ltd Proposes Special Dividend for the 2021